Hunter Gillies, CHIEF MEDICAL OFFICER at Aerovate Therapeutics, Inc. (AVTE), sold 65 shares at $19.50 ($1K) on 2023-05-19, disclosed to the SEC on 2023-05-23.
Scheduled sale ($1k) by CHIEF MEDICAL OFFICER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| AVTE | SELL | 2024-04-19 | $172K | — | Filing → |
| AVTE | SELL | 2024-04-01 | $266K | — | Filing → |
| AVTE | SELL | 2024-03-20 | $346K | — | Filing → |